In the News | Friends of Cancer Research

You are here

In the News

February 8, 2019
SOME CANCER PATIENTS hope to join clinical trials, both to gain access to new treatments and to help improve treatment for future patients. Yet clinical trial eligibility requirements often state... Read more
February 5, 2019
Cancer in adolescents and young adults Her untimely death has once again shone a light on a global subgroup of 1 million cancer patients, referred to as adolescents and young adults (AYA), who, as of... Read more
February 1, 2019
Easing comorbid-condition exclusion criteria could significantly increase participation in clinical trials for cancer, researchers report.   "Some eligibility exclusions for comorbid conditions will... Read more
February 1, 2019
The Lung Cancer Master Protocol is undergoing a major expansion to include patients with all non-small cell lung cancers.   The trial previously tested treatments for people with advanced stage... Read more
February 1, 2019
FDA is enhancing its ability to handle real-world evidence by training reviewers in data science via a curriculum on machine learning and artificial intelligence, said FDA Commissioner Scott Gottlieb... Read more
February 1, 2019
The Lung Cancer Master Protocol (Lung-MAP), the first precision medicine trial in lung cancer supported by the National Cancer Institute (NCI), is undergoing a major expansion to include patients... Read more
January 31, 2019
A pair of former FDA commissioners debated whether FDA should take the lead on using real-world data and real-world evidence to determine the actual value of drug therapies and in turn ensure the... Read more
January 29, 2019
Stressing the need for speed and efficiency, FDA Commissioner Scott Gottlieb on Monday offered a look at FDA’s plans around real-world data (RWD) and real-world evidence (RWE) in 2019.   The speech... Read more
January 29, 2019
Randomized controlled clinical trials are a great way to test the safety and effectiveness of a new drug. But when the trial is over and the drug approved, it’s used by patients and health care... Read more
January 29, 2019
Real-world evidence (RWE) or real-world data (RWD) relates to the collection of information about a drug’s safety and efficacy outside the structure of a clinical trial. Speaking yesterday at the... Read more

Pages